KEI Reports and Posts

2020. September 4. BARDA is investigating Moderna’s failures to disclose BARDA funding in patent applications.

2020. September 2. KEI request to BARDA concerning Moderna obligations to disclose federal funding in patent applications.

2020. August 30. DARPA announces investigation into Moderna’s apparent failures to disclose mRNA vaccine patents.

2020. August 28. KEI asks DOD to investigate failure to disclose DARPA funding in Moderna patents.

2020. August 27. 2020:3 KEI Research Note: Moderna failures to disclose DARPA funding in patented inventions.

2020. August 5. BARDA Responds to KEI, Public Citizen Letter Asking BARDA to Enforce Moderna Contract.

2020. August 4. KEI and Public Citizen request BARDA to address Moderna’s noncompliance with COVID-19 vaccine contract term.

2020. July 1. KEI receives seven new contracts for COVID 19 research from BARDA and DOD, including five using “Other Transactions Authority” that weaken or eliminate Bayh-Dole and FAR Safeguards.

2020. May 21. Moderna and US Government Funding of its COVID-19 Vaccine Candidate.

Press Coverage

Washington Post
2020. August 28. “Moderna failed to disclose federal support in vaccine patents, researchers say: The company with a leading coronavirus vaccine candidate did not adhere to a law designed to protect public investment.” Washington Post. Christopher Rowland.

2020. August 29. “Moderna’s Patents Probed by U.S. Defense Department, FT Says.” Bloomberg. Chiara Vasarri.

2020. August 5. “Moderna skirts disclosures of coronavirus vaccine costs.” Axios. Bob Herman.

2020. September 4. “A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents.” STAT. Ed Silverman.

2020. August 8. “Moderna failed to disclose federal funding for vaccine patent applications, advocates say.” STAT. Ed Silverman.

2020. August 4. “BARDA faces pressure to force Moderna to disclose cost details from its Covid-19 contract.” Ed Silverman.

Financial Times
2020. August 29. “US government’s Darpa probes Moderna’s vaccine patents: Researchers accuse biotech company of failing to disclose federal grants in patents which also cover Covid-19 candidate.” Financial Times. Donato Paolo Mancini.

National Public Radio (NPR)
2020. August 4. “Prices For COVID-19 Vaccines Are Starting To Come Into Focus.” NPR. Sydney Lupkin.

Health Policy Watch
2020. September 3. “US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding.” Health Policy Watch. Grace Ren.

2020. September 1. “US Department Of Defense Is Investigating Moderna’s Patents For Allegedly Failing To Disclose Federal Support.” Health Policy Watch. Grace Ren.

The Pharma Letter
2020. September 4. “Non-profit says Moderna hid federal funding from patent office.” The Pharma Letter.

Life Sciences Intellectual Property Review
2020. September 8. “Moderna’s COVID-19 and Zika patent applications to be investigated.” Life Sciences Intellectual Property Review. Muireann Bolger.

2020. September 4. “HHS Unit Probes Funding For Moderna’s Patented Vaccines.” Law360. Kevin Stawicki.

2020. August 31. “DOD Investigating Moderna’s Vaccine Patents.” Law360. Kevin Stawicki.

2020. August 28. “Activists Say Moderna Hid Gov’t Support For Vaccine Patents.” Law360. Kevin Stawicki.

The Motley Fool

2020. September 2. “How You Might Own a Stake in Moderna’s Coronavirus Vaccine Without Even Knowing It.” The Motley Fool. Keith Speights.

2020. August 31. “Why Moderna Stock Fell Today: The coronavirus vaccine maker is being investigated for failing to disclose government funding in its patent applications.” The Motley Fool.

Other Trade/Financial Press

2020. August 31. “Moderna’s Patent Filings, Applications Under Defense Department Review: Report.” Benzinga. Shanthi Rexaline.

2020. August 30. “Moderna failed to disclose government grants that funded the development of its patented vaccines, an advocacy group claims.” Seeking Alpha. Eli Hoffmann.

2020. September 1. “MRNA Stock News: Moderna defies gravity, set to rise amid coronavirus vaccine rush: A probe by the US Department of Defense is a third adverse factor.” FX Street. Yohay Elam.

2020. August 30. “Moderna’s Vaccine Patents Under Review.” Precision Vaccinations. Don Ward Hackett.